- Article
On the Stability and Degradation Pathways of Venetoclax under Stress Conditions
- Nina Žigart,
- Martin Črnugelj,
- Janez Ilaš and
- Zdenko Časar
Venetoclax is an orally bioavailable, B-cell lymphoma-2 (BCL-2) selective inhibitor, used for the treatment of various types of blood cancers, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). In this study we investiga...